A functional medicine Lyme expert can help determine the right timing, dosage, and combinations to avoid interference and enhance healing
Cetilistat, a lipase inhibitor, is being tested in phase 3 trials and is claimed to be safer than orlistat
Generic medications tend to be Sandoz is building its GLP-1 development platform, and this submission reflects true in-house innovation, said Claire DAbreu-Hayling, the president of Generics Development and the chief scientific officer at Sandoz, in a press statement
But most patients drop off the drugs before one year: Among GLP-1 patients with obesity who fill their first prescription, just 32% are still taking their medication 13 months later, per November IQVIA analysis
Lecanemab, approved by the Food and Drug Administration last year, and donanemab, out earlier this month, are both antibody treatments built around the idea that reducing the presence of key amyloid plaques in the brain will help slow dementia progression